Physician profile
Jules E Garbus
NPI 1356310809
$3,386.67
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,313 · 2020: $43.30 · 2021: $30.03.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2019 | |
| Integra Lifesciences Corporation | $137.10 | 2019 | |
| Baxter Healthcare | $90.66 | 2019-2021 | |
| Acell, INC. | $43.22 | 2019 | |
| Shire North American Group INC | $41.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.57 | 2019 | |
| Alfasigma USA, INC. | $18.97 | 2020 | |
| Glaxosmithkline, LLC. | $16.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jules Garbus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.